Medium to long-term echo follow-up after ventricular septal defect device closure

Muhammed Riyas K Rahmath1, Mohammed Numan2, Muhammad Dilawar3

  • 1Division of Pediatric Cardiac Surgery, Hamad General Hospital, Doha, Qatar.

Insights

Percutaneous closure of ventricular septal defects using Amplatzer devices is effective, with a 91% success rate. Long-term echocardiographic follow-up is crucial for monitoring potential device-related aortic and tricuspid valve regurgitation.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pediatric Cardiology

Background:

  • Ventricular septal defects (VSDs) are common congenital heart abnormalities.
  • Transcatheter closure offers an alternative to surgical repair for VSDs.
  • Amplatzer devices are frequently used for percutaneous VSD closure.

Purpose of the Study:

  • To evaluate the medium to long-term echocardiographic outcomes of perimembranous and muscular VSD closure using Amplatzer devices.
  • To assess the efficacy and safety of transcatheter VSD closure.
  • To identify potential device-related complications.

Main Methods:

  • Retrospective analysis of 49 patients undergoing percutaneous VSD closure with Amplatzer devices.
  • Detailed echocardiographic assessment including transthoracic and transesophageal views.
  • Follow-up duration averaged 54.5 months.

Main Results:

  • Successful closure achieved in 45/49 patients (91.84% success rate).
  • Complete closure observed in 91% of patients at follow-up; 9% had tiny residual defects.
  • Mild aortic regurgitation developed in 13.3% and tricuspid regurgitation in 29% of patients.

Conclusions:

  • Transcatheter closure of perimembranous and muscular VSDs with Amplatzer devices is an effective procedure.
  • Regular echocardiographic follow-up is essential to monitor for device-related complications, particularly valvular regurgitation.
  • Long-term surveillance is recommended for patients undergoing percutaneous VSD closure.
Abstract